Shipped in a discreet, unmarked envelope with all required documents enclosed.
Product Sheet
Active Ingredient(s)
Carbidopa, Levodopa
Reference Brand
Sinemet
Product Origin
Generic Product
Reference Manufacturer
Merck
Product Form
Tablet
Regulatory Classification
Rx
Primary Category
Neurology
Product Category
Antiparkinsonian agent
Pharmacological Class
Dopamine precursor
Clinical Indications
Parkinson disease
Manufacturer Description
This medication is utilized to address symptoms of Parkinson disease by replenishing dopamine levels to support improved physical coordination.
Mechanism of Action
Levodopa crosses the blood-brain barrier to be converted into dopamine, while carbidopa prevents its breakdown in the body, ensuring more reaches the brain to improve motor function.
Route of Administration
Oral
Onset Time
30-60 minutes
Duration
3-6 hours
Contraindications
Narrow-angle glaucoma
Severe Adverse Events
Hallucinations, Orthostatic hypotension
Common Side Effects
Nausea, Dizziness, Dry mouth
Uncommon Side Effects
Dyskinesia, Confusion
Drug Interactions
MAO inhibitors
Pregnancy Safety Warnings
Consult a healthcare professional.
Age Restrictions
Safety in children not established.
Storage Guidelines
Store in a cool, dry place.
Related Products
Pramipexole, Ropinirole
Information associated with Carbidopa with Levodopa is curated and periodically reviewed using established medical references and prescribing guidelines. Content is intended for general awareness and should be verified with a licensed healthcare professional before use.
